DSGN – design therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Design Therapeutics (DSGN) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
Design Therapeutics Maps H2 Data Readouts for RESTORE-FA, FECD Biomarker Study and DM1 Program [Yahoo! Finance]
Design Therapeutics (DSGN) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00. They now have an "outperform" rating on the stock.
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates [Yahoo! Finance]
Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates
Form SCHEDULE 13D/A Design Therapeutics, Filed by: SR One Capital Fund I Aggregator LP
Form S-8 Design Therapeutics,
Form 10-K Design Therapeutics, For: Dec 31
Form 8-K Design Therapeutics, For: Mar 09
Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.